The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
A MicroRNA Signature of Hypoxia
Open accessAbstract
Recent research has identified critical roles for microRNAs in a large number of cellular processes, including tumorigenic transformation. While significant progress has been made towards understanding the mechanisms of gene regulation by microRNAs, much less is known about factors affecting the expression of these noncoding transcripts. Here, we demonstrate for the first time a functional link between hypoxia, a well-documented tumor microenvironment factor, and microRNA expression. Microarray-based expression profiles revealed that a specific spectrum of microRNAs (including miR-23, -24, -26, -27, -103, -107, -181, -210, and -213) is induced in response to low oxygen, at least some via a hypoxia-inducible-factor-dependent mechanism. Select members of this group (miR-26, -107, and -210) decrease proapoptotic signaling in a hypoxic environment, suggesting an impact of these transcripts on tumor formation. Interestingly, the vast majority of hypoxia-induced microRNAs are also overexpressed in a variety of human tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“miR-23a was induced under hypoxic circumstances and can ultimately act upon pro-apoptotic signals to promote tumor formation and oncogenic transformation [89].”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [89]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Another factor that can induce miR-21 expression is hypoxia, a general feature of all solid tumors (30).”
From MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators (2008) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Self-citationJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“to-alanine substitutions have been described previously (14, 15).”
MethodSelf-citationCombinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Self-citationmiRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 1,000
Hypoxia-Inducible Factors and Cancer
Jun, J. C., Rathore, A., Younas, H., Gilkes, D., & Polotsky, V. Y. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0062-7 · Cited by 248
Qiu, G., Jin, M., Dai, J., Sun, W., Feng, J., & Jin, W. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 250
Dysregulation of microRNA biogenesis and gene silencing in cancer
Hata, A., & Lieberman, J. (2015) · Science Signaling · doi:10.1126/scisignal.2005825 · Cited by 239
MicroRNAs in human cancer: from research to therapy
Negrini, M., Ferracin, M., Sabbioni, S., & Croce, C. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03450 · Cited by 241
Self-citationMIR-210 modulates mitochondrial respiration in placenta with preeclampsia
Muralimanoharan, S., Maloyan, A., Mele, J., Guo, C., Myatt, L. G., & Myatt, L. (2012) · Placenta · doi:10.1016/j.placenta.2012.07.002 · Cited by 237
microRNA: A Master Regulator of Cellular Processes for Bioengineering Systems
Sun, W., Li, Y.-S. J., Huang, H., Shyy, J. Y.-J., & Chien, S. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105314 · Cited by 242
Zhang, Y., Fei, M., Xue, G., Zhou, Q., Jia, Y., Li, L., Xin, H., & Sun, S. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01291.x · Cited by 236
Reprogramming mRNA translation during stress
Yamasaki, S., & Anderson, P. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.013 · Cited by 238
Jung, M., Mollenkopf, H., Grimm, C., Wagner, I., Albrecht, M., Waller, T., Pilarsky, C., Johannsen, M., Stephan, C., Lehrach, H., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00705.x · Cited by 249
Identification of a MicroRNA Panel for Clear-cell Kidney Cancer
Juan, D., Alexe, G., Antes, T. J., Liu, H., Madabhushi, A., DeLisi, C., Ganesan, S., Bhanot, G. V., & Liou, L. S. (2009) · Urology · doi:10.1016/j.urology.2009.10.033 · Cited by 225
Ovcharenko, D., Kelnar, K., Johnson, C. D., Leng, N., & Brown, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1484 · Cited by 225
miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells
Cascio, S., D’Andrea, A., Ferla, R., Surmacz, E., Gulotta, E., Amodeo, V., Bazan, V., Gebbia, N., & Russo, A. D. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22126 · Cited by 223
Gene regulation under low oxygen: holding your breath for transcription
Rocha, S. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.005 · Cited by 215
Kelly, T. J., Souza, A. L., Clish, C. B., & Puigserver, P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01242-10 · Cited by 222
Rothé, F., Ignatiadis, M., Chaboteaux, C., Haibe‐Kains, B., Kheddoumi, N., Majjaj, S., Badran, B. M., Fayyad‐Kazan, H., Desmedt, C., Harris, A. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020980 · Cited by 227
Sarkar, J., Gou, D., Turaka, P., Viktorova, E., Ramchandran, R., & Raj, J. U. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00201.2010 · Cited by 215
Chow, T.-F. F., Youssef, Y. M., Lianidou, E. S., Romaschin, A. D., Honey, R. J. D., Stewart, R., Pace, K. T., & Yousef, G. M. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.07.020 · Cited by 214
MicroRNA-26a Regulates Pathological and Physiological Angiogenesis by Targeting BMP/SMAD1 Signaling
Icli, B., Wara, A. K. M., Moslehi, J., Sun, X., Plovie, E., Cahill, M., Marchini, J. F., Schissler, A., Padera, R. F., Shi, J., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301780 · Cited by 211
Bavelloni, A., Ramazzotti, G., Poli, A., Piazzi, M., Focaccia, E., Blalock, W. L., & Faenza, I. (2017) · Anticancer Research · doi:10.21873/anticanres.12107 · Cited by 210
MicroRNA regulons in tumor microenvironment
Suzuki, H. I., Katsura, A., Matsuyama, H., & Miyazono, K. (2014) · Oncogene · doi:10.1038/onc.2014.254 · Cited by 210
MicroRNAs and cancer: Profile, profile, profile
Barbarotto, E., Schmittgen, T. D., & Calin, G. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.23343 · Cited by 210
Self-citationReactive oxygen species and HIF-1 signalling in cancer
Galanis, Α., Pappa, A., Giannakakis, A., Lanitis, E., Laniti, D. D., & Sandaltzopoulos, R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.028 · Cited by 210
Micro RNA s play a central role in molecular dysfunctions linking inflammation with cancer
Tili, E., Michaille, J., & Croce, C. M. (2013) · Immunological Reviews · doi:10.1111/imr.12050 · Cited by 211
Self-citationDentelli, P., Rosso, A., Orso, F., Olgasi, C., Taverna, D., & Brizzi, M. F. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.206201 · Cited by 205
Tsuchiya, S., Fujiwara, T., Sato, F., Shimada, Y., Tanaka, E. I., Sakai, Y., Shimizu, K., & Tsujimoto, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170852 · Cited by 203
Wada, S., Kato, Y., Okutsu, M., Miyaki, S., Suzuki, K., Yan, Z., Schiaffino, S., Asahara, H., Ushida, T., & Akimoto, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271270 · Cited by 204
Ortiz-Barahona, A., Villar, D., Pescador, N., Amigo, J., & del Peso, L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1205 · Cited by 202
Gene regulation by non-coding RNAs
Patil, V. S., Zhou, R., & Rana, T. M. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.844092 · Cited by 210
Bagińska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 204
Gestational Hypoxia and Developmental Plasticity
Ducsay, C. A., Goyal, R., Pearce, W. J., Wilson, S. M., Hu, X., & Zhang, L. (2018) · Physiological Reviews · doi:10.1152/physrev.00043.2017 · Cited by 208
MiRNAs: Biology, Biogenesis, their Web-based Tools, and Databases
Tafrihi, M., & Hasheminasabgorji, E. (2018) · MicroRNA · doi:10.2174/2211536607666180827111633 · Cited by 196
Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies
Wu, L., Zhou, H., Lin, H., Qi, J., Zhu, C., Gao, Z., & Wang, H. (2011) · Reproduction · doi:10.1530/rep-11-0304 · Cited by 192
Hypoxia response and microRNAs: no longer two separate worlds
Ivan, M., Harris, A. L., Martelli, F., & Kulshreshtha, R. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00398.x · Cited by 198
Self-citationmicroRNAs: A Safeguard against Turmoil?
Leung, A. K. L., & Sharp, P. A. (2007) · Cell · doi:10.1016/j.cell.2007.08.010 · Cited by 196
The Role of Epigenetics in Placental Development and the Etiology of Preeclampsia
Apicella, C., Ruano, C. S. M., Méhats, C., Miralles, F., & Vaiman, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112837 · Cited by 203
miRNAs as Modulators of AngiogenesisPreprint
Landskroner-Eiger, S., Moneke, I., & Sessa, W. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006643 · Cited by 190
White, N. M. A., Bao, T. T., Grigull, J., Youssef, Y. M., Girgis, A. H., Diamandis, M., Fatoohi, E., Metias, M., Honey, R. J. D., Stewart, R., et al. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.04.110 · Cited by 191
Hypoxia induces microRNA miR‐210 in vitro and in vivo
Pulkkinen, K. H., Malm, T., Turunen, M. P., Koıstınaho, J., & Ylä‐Herttuala, S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.048 · Cited by 191
MicroRNA-mediated control of macrophages and its implications for cancer
Squadrito, M. L., Etzrodt, M., Palma, M. D., & Pittet, M. J. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.02.003 · Cited by 190
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
Zhou, B., Ma, R., Si, W., Li, S., Yan, X., Tu, X., & Wang, Q. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.028 · Cited by 188
Hypoxia-Inducible miR-210 Regulates the Susceptibility of Tumor Cells to Lysis by Cytotoxic T Cells
Noman, M. Z., Buart, S., Romero, P. J., Ketari, S., Janji, B., Mari, B. P., Mami‐Chouaib, F., & Chouaı̈b, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1383 · Cited by 188
New horizons in hypoxia signaling pathways
Pugh, C. W., & Ratcliffe, P. J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.008 · Cited by 186
Ibáñez‐Ventoso, C., Vora, M., & Driscoll, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002818 · Cited by 189
Bao, B., Azmi, A. S., Ali, S. S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 181
Jardim, M. J., Fry, R. C., Jaspers, I., Dailey, L. A., & Díaz-Sánchez, D. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0900756 · Cited by 180
Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis
Chen, Z. B., Lai, T., Jan, Y., Lin, F., Wang, W.-C., Xiao, H., Wang, Y., Sun, W., Cui, X., Li, Y.-S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65344 · Cited by 180
Bao, B., Ali, S. S., Ahmad, A., Azmi, A. S., Li, Y., Banerjee, S., Kong, D., Sethi, S. N., Aboukameel, A., Padhyé, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050165 · Cited by 178
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Jubb, A. M., Buffa, F. M., & Harris, A. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00944.x · Cited by 175
Mutharasan, R. K., Nagpal, V., Ichikawa, Y., & Ardehali, H. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01080.2010 · Cited by 175
Circulating microRNAs as Candidate Markers to Distinguish Heart Failure in Breathless Patients
Ellis, K. L., Cameron, V. A., Troughton, R. W., Frampton, C. M., Ellmers, L. J., & Richards, M. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft078 · Cited by 177
microRNA: Emerging therapeutic targets in acute ischemic diseases
Fasanaro, P., Greco, S., Ivan, M., Capogrossi, M. C., & Martelli, F. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.003 · Cited by 175
Self-citationDelayed ischemic preconditioning contributes to renal protection by upregulation of miR-21
Xu, X., Kriegel, A. J., Liu, Y., Usa, K., Mladinov, D., Liu, H., Fang, Y., Ding, X., & Liang, M. (2012) · Kidney International · doi:10.1038/ki.2012.241 · Cited by 177
Cheng, H. H., Mitchell, P. S., Kroh, E. M., Dowell, A. E., Chery, L. J., Siddiqui, J., Nelson, P. S., Vessella, R. L., Knudsen, B. S., Chinnaiyan, A. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069239 · Cited by 171
Du, R., Sun, W., Xia, L., Zhao, A., Yu, Y., Zhao, L., Wang, H., Huang, C., & Sun, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030771 · Cited by 176
Functional regulation of HIF‐1α under normoxia—is there more than post‐translational regulation?
Kuschel, A., Simon, P. D., & Tug, S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22798 · Cited by 174
Circulating MicroRNAs and Aerobic Fitness – The HUNT-Study
Bye, A., Røsjø, H. R., Aspenes, S. T., Condorelli, G., Omland, T., & Wisløff, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057496 · Cited by 166
MicroRNA Profiling and Head and Neck Cancer
Liu, X., Chen, Z., Yu, J., Xia, J., & Zhou, X. C. (2009) · Comparative and Functional Genomics · doi:10.1155/2009/837514 · Cited by 165
Multiple functions of hypoxia-regulated miR-210 in cancer
Qin, Q., Furong, W., & Li, B. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-50 · Cited by 170
Li, B., Dasgupta, C., Huang, L., Meng, X., & Zhang, L. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0257-6 · Cited by 168
Wang, M., Li, W., Chang, G., Ye, C., Ou, J., Li, X., Liu, Y., Cheang, T., Huang, X., & Wang, S. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.229559 · Cited by 164
Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit
Costales, M. G., Haga, C. L., Velagapudi, S. P., Childs‐Disney, J. L., Phinney, D. G., & Disney, M. D. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11273 · Cited by 165
Xu, Q., Liu, X., Liu, Z., Zhou, Z., Wang, Y., Tu, J., Li, L., Bao, H.-X., Yang, L., & Tu, K. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0675-y · Cited by 165
Thangaraju, K., Neerukonda, S. N., Katneni, U., & Buehler, P. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010153 · Cited by 167
Hypoxia-regulated microRNAs in human cancer
Shen, G., Li, X., Jia, Y.-F., Piazza, G. A., & Xi, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.195 · Cited by 164
Regulatory mechanisms of microRNAs involvement in cancer
Fabbri, M., Ivan, M., Cimmino, A., Negrini, M., & Calin, G. A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1009 · Cited by 167
Self-citationMicroRNAs , transforming growth factor beta‐1, and tissue fibrosis
Bowen, T., Jenkins, R. L., & Fraser, D. J. (2012) · The Journal of Pathology · doi:10.1002/path.4119 · Cited by 166
Span, P. N., & Bussink, J. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.10.002 · Cited by 169
miR-23b* targets proline oxidase, a novel tumor suppressor protein in renal cancer
Liu, W., Zabirnyk, O., Wang, H., Shiao, Y., Nickerson, M. L., Khalil, S., Anderson, L. M., Perantoni, A. O., & Phang, J. M. (2010) · Oncogene · doi:10.1038/onc.2010.237 · Cited by 164
Strategies for hypoxia adaptation in fish species: a review
Zhu, C.-D., Wang, Z., & Yan, B. (2013) · Journal of Comparative Physiology B · doi:10.1007/s00360-013-0762-3 · Cited by 159
Alhasan, A. H., Kim, D. Y., Daniel, W. L., Watson, E., Meeks, J. J., Thaxton, C. S., & Mirkin, C. A. (2012) · Analytical Chemistry · doi:10.1021/ac3004055 · Cited by 158
Camps, C., Saini, H. K., Mole, D. R., Choudhry, H., Reczko, M., Guerra‐Assunção, J. A., Tian, Y., Buffa, F. M., Harris, A. L., Hatzigeorgiou, A. G., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-28 · Cited by 163
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Sotiropoulou, G., Pampalakis, G., Lianidou, E. S., & Mourelatos, Z. (2009) · RNA · doi:10.1261/rna.1534709 · Cited by 158
MicroRNAs: crucial regulators of placental development
Hayder, H., O’Brien, J. A., Nadeem, U., & Peng, C. (2018) · Reproduction · doi:10.1530/rep-17-0603 · Cited by 160
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents
Khoshnam, S. E., Winlow, W., Farbood, Y., Moghaddam, H. F., & Farzaneh, M. (2017) · Journal of Stroke · doi:10.5853/jos.2016.01368 · Cited by 156
Assmann, T. S., Recamonde‐Mendoza, M., de Souza, B. M., & Crispim, D. (2017) · Endocrine Connections · doi:10.1530/ec-17-0248 · Cited by 158
Hypoxia and chronic lung disease
Tuder, R. M., Yun, J. H., Bhunia, A. K., & Fijałkowska, I. J. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0280-4 · Cited by 154
HIF-1 versus HIF-2 — Is one more important than the other?
Loboda, A., Jozkowicz, A., & Dulak, J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.006 · Cited by 152
Kim, J. H., Park, S., Song, S.-Y., Kim, J. K., & Sung, J.-H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.117 · Cited by 154
Angiogenesis-regulating microRNAs and Ischemic Stroke
Yin, K., Hamblin, M., & Chen, Y. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990016 · Cited by 153
Estrogen Regulation of MicroRNA Expression
Klinge, C. (2009) · Current Genomics · doi:10.2174/138920209788185289 · Cited by 156
Hypoxia, HIFs and bone development
Araldi, E., & Schipani, E. (2010) · Bone · doi:10.1016/j.bone.2010.04.606 · Cited by 153
Prueitt, R. L., Yi, M., Hudson, R. S., Wallace, T. A., Howe, T. M., Yfantis, H. G., Lee, D. H., Stephens, R. M., Liu, C., Calin, G. A., et al. (2008) · The Prostate · doi:10.1002/pros.20786 · Cited by 148
Self-citationEditorial focus: understanding off-target effects as the key to successful RNAi therapy
Bartoszewski, R., & Sikorski, A. F. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0196-3 · Cited by 157
Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing
Agrawal, R., Pandey, P., Jha, P., Dwivedi, V. K., Sarkar, C., & Kulshreshtha, R. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-686 · Cited by 147
Self-citationYeung, C. L. A., Tsang, T. Y., Yau, P., & Kwok, T. T. (2011) · Oncogene · doi:10.1038/onc.2010.613 · Cited by 146
Coppola, V., Maria, R. D., & Bonci, D. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0172 · Cited by 152
Li, W., Zhang, X., Zhuang, H., Chen, H.-G., Chen, Y., Tian, W., Wu, W., Li, Y., Wang, S., Zhang, L., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537050 · Cited by 145
Peng, J., Omran, A. G., Ashhab, M. U., Kong, H., Gan, N., He, F. P., & Yin, F. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9953-3 · Cited by 146
Hypoxia‐Inducible Exosomes Facilitate Liver‐Tropic Premetastatic Niche in Colorectal Cancer
Sun, H., Meng, Q., Shi, C., Yang, H., Li, X., Wu, S., Familiari, G., Relucenti, M., Aschner, M., Wang, X., et al. (2021) · Hepatology · doi:10.1002/hep.32009 · Cited by 144
Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells
Jung, K. O., Youn, H., Lee, C., Kang, K. W., & Chung, J. (2016) · Oncotarget · doi:10.18632/oncotarget.14247 · Cited by 143
Control of mitochondrial activity by miRNAs
Li, P., Jiao, J., Gao, G., & Prabhakar, B. S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24004 · Cited by 145
Voellenkle, C., García-Manteiga, J. M., Pedrotti, S., Perfetti, A., Toma, I. D., Silva, D. D., Maimone, B., Greco, S., Fasanaro, P., Creo, P., et al. (2016) · Scientific Reports · doi:10.1038/srep24141 · Cited by 141
Bartoszewska, S., Rochan, K., Piotrowski, A., Kamysz, W., Ochocka, J. R., Collawn, J. F., & Bartoszewski, R. (2014) · The FASEB Journal · doi:10.1096/fj.14-267054 · Cited by 139
microRNA-mediated regulation of the tumor microenvironment
Chou, J., Shahi, P., & Werb, Z. (2013) · Cell Cycle · doi:10.4161/cc.26087 · Cited by 141
miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
Wu, M.-Z., Cheng, W., Chen, S.-F., Nieh, S., O’Connor, C., Liu, C., Tsai, W., Wu, C.-J., Martin, L., Lin, Y., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3615 · Cited by 139
Self-citationmiR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia
Gou, D., Ramchandran, R., Peng, X., Yao, L., Kang, K., Sarkar, J., Wang, Z., Zhou, G., & Raj, J. U. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00344.2011 · Cited by 139
MicroRNA in colorectal cancer: from benchtop to bedside
Wu, W. K. K., Law, P. T. Y., Lee, C. W., Cho, C. H., Fan, D., Wu, K., Yu, J. Q., & Sung, J. J. �. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq243 · Cited by 138
Bao, B., Ahmad, A., Kong, D., Ali, S. S., Azmi, A. S., Li, Y., Banerjee, S., Padhyé, S., & Sarkar, F. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043726 · Cited by 137
MicroRNAs in skin and wound healing
Banerjee, J., Chan, Y. C., & Sen, C. K. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2010 · Cited by 139
Dhawan, A., Scott, J. G., Harris, A. L., & Buffa, F. M. (2018) · Nature Communications · doi:10.1038/s41467-018-07657-1 · Cited by 142
Metadata
- Authors
- Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C.-G., Croce, C. M., Negrini, M., Calin, G. A., & Ivan, M.
- Affiliations
- Tufts Medical Center (US)
- University of Ferrara (IT)
- The Ohio State University (US)
- Comprehensive Cancer Center, Ohio State University
- Corresponding author
- Ivan, Mircea
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-03-01
- Volume
- 27
- Issue
- 5
- Pages
- 1859-1867
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1820461
- OpenAlex
- W2116000203
- Cited by
- 1,055
- References
- 31
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 26 · 2023: 32 · 2022: 45 · 2021: 50 · 2020: 43 · 2019: 54 · 2018: 38 · 2017: 70 · 2016: 63 · 2015: 73 · 2014: 91 · 2013: 93 · 2012: 81
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-34928, P30DK034928)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- microRNA, hypoxia, hypoxia-inducible factor, miR-210, miR-26, miR-107, tumor microenvironment, tumor formation, apoptosis, miRNA expression profiling, non-coding RNA regulation
- MeSH terms
- Breast Neoplasms, Colonic Neoplasms, Female, Humans, Luciferases, Plasmids, Transfection, Cell Hypoxia, Apoptosis, Genes, Reporter, HT29 Cells, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, MicroRNAs, HCT116 Cells, Cell Line, Tumor, Chromatin Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review